Autumn Glory Partners’s Biogen BIIB Stock Holding History

Autumn Glory Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,184	Closed	-$617K	–	179
2024 Q3	$617K	Hold	3,184	–	–	0.24%	111
2024 Q2	$738K	Hold	3,184	–	–	0.38%	78
2024 Q1	$687K	Hold	3,184	–	–	0.34%	79
2023 Q4	$823K	Buy	3,184 +63	+2%	+$15.5K	0.47%	67
2023 Q3	$802K	Buy	3,121 +19	+0.6%	+$5.08K	0.49%	64
2023 Q2	$884K	Buy	+3,102	New	+$923K	0.65%	50
2023 Q1	–	Sell	-3,057	Closed	-$847K	–	136
2022 Q4	$847K	Sell	3,057 -823	-21%	-$232K	0.45%	69
2022 Q3	$1.04M	Buy	+3,880	New	+$824K	0.7%	51
2022 Q2	–	Sell	-3,222	Closed	-$679K	–	158
2022 Q1	$679K	Sell	3,222 -3,222	-50%	-$701K	0.39%	80
2021 Q4	$1.55M	Buy	+6,444	New	+$1.66M	0.65%	50

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Autumn Glory Partners's BIIB Position: Q4 2024 in Review

Autumn Glory Partners sold out of Biogen (BIIB) in Q4 2024, closing a stake of 3,184 shares — an estimated $617K sold.

Autumn Glory Partners first reported a position in BIIB in Q4 2021 and held it in 10 quarters. The position peaked at $1.55M in Q4 2021. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

Autumn Glory Partners reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
Autumn Glory Partners sold 3,184 Biogen shares in Q4 2024, an estimated $617K.
Autumn Glory Partners first reported a position in Biogen in Q4 2021 and held it in 10 quarters.
Autumn Glory Partners's Biogen position peaked at $1.55M in Q4 2021.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Autumn Glory Partners's 13F filing for Q4 2024, filed 30 Jan 2025.